The European Medicines Agency could lose up to half its nearly 900-strong staff if the agency moves from London following the departure of the UK from the EU. Nonetheless, the agency is determined to avoid disruption to its operations and to continue to meet its public health obligations, both in the run-up to Brexit and following it.
“What we cannot afford – no matter what happens – is a disruption of our operations or a delay in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?